Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

Press releases published on June 15, 2026

Sparrow Pharmaceuticals Announces Interim CAPTAIN-T2D Data Validating High Prevalence of Elevated Cortisol in Difficult-to-Control Type 2 Diabetes
Fate Therapeutics Appoints Laura Hamill to Board of Directors
NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
Sienna Announces June Dividend
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas
SpyGlass Pharma Appoints Shannon Treviño as General Counsel
KFSH Highlights Provider Transformation Through Measurable Operational Impact at HLTH Europe 2026
Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India
Das KFSH stellt auf der HLTH Europe 2026 die Transformation von Gesundheitsdienstleistern anhand messbarer betrieblicher Ergebnisse vor
Le KFSH met en avant la transformation des prestataires grâce à un impact opérationnel mesurable au HLTH Europe 2026
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Spyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Among the First in the U.S., Sutter Health Performs Robotic Single-Port Nipple-Sparing Mastectomy

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Wellness Wire Kansas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.